Dark Horse Consulting Group Inc.
Ian Pardo has extensive experience in quality assurance and consultancy within the pharmaceutical industry. Currently a Senior Practice Expert Quality and Principal Consultant at Dark Horse Consulting Group Inc. since November 2019, Ian previously served as Company Director and EU QP at Spires Quality Limited from September 2017 to April 2021. Other notable roles include Qualified Person and Senior Quality Specialist at Oxford Biomedica, EU Qualified Person and Senior Quality Manager at Pfizer, and Quality Manager at Circassia. Ian's educational background includes multiple MSc degrees in Molecular Parasitology and Vector Biology from The University of Manchester, Keele University, and The University of Salford, as well as a BSc in Molecular Genetics in Biotechnology from the University of Sussex and certification as an EU Qualified Person from NSF Health Sciences.
This person is not in any offices
Dark Horse Consulting Group Inc.
AT DARK HORSE CONSULTING, we work to accelerate cell and gene therapies through our unmatched expertise. Our consulting team has extensive CGT industry experience with knowledge spanning manufacturing, process development, comparability, analytical dev, quant modeling, quality systems, regulatory support, preclinical dev, device dev, program management, facility design and enginnering, market research, and due diligence and business strategy. Many of our consultants also bring experience from adjacent, more mature, sectors, including traditional biologics, small molecules, medical devices, and management consulting. Client requests range from scientific expertise to tactical needs to strategic considerations to business development. We understand the unique challenges faced by Cell and Gene Therapy developers like none other. We apply best practices from across this and other industries to address the needs of our clients, who range from biopharmaceutical companies to tools & tech providers to investment firms.